Although studies have shown that AGAP2-AS1 may be a potential biomarker for early diagnosis and prognosis of various tumors, its role in kidney cancer, especially in ccRCC, is still unclear [17, 18]. This evidence concerns the gene AGAP2 and nonpapillary renal cell carcinoma.